European manufacturers are complaining that one of their largest export markets — Turkey — has unfairly erected barriers to doing business in the country. The European Union has responded by filing a dispute with the World Trade Organization.
In its complaint, filed on April 2, the EU maintained the Turkish government has taken several steps that are designed to bolster its economy and local producers at the expense of foreign drug makers selling their medicines there. And the moves could potentially affect EU pharmaceutical exports worth approximately $520 million.
About the Author Reprints
May I observe that I was happy to see this appear toward the end of this post – “As for technology transfer as a condition of market access, he continued, “we [ also ] saw this in China…” I was made aware of this 15+ years ago and it had been concerning companies well before I became aware.